Join advanced therapies stakeholders for the free virtual Advanced Therapies Manufacturing Strategy Summit, July 14-15, to take stock of the first half of 2020 and the short and long term implications of the ongoing COVID-19 pandemic. Registration is free (vendors and solution providers, please note your registration is not free). . 

Hear an update on FDA regulatory guidance for manufacturers, take part in a virtual Q&A, and gain insight on current consortia initiatives and priorities for cell and gene therapy manufacturing and commercial development. Some industry leaders joining us include: 

• Peter Marks MD, PhD, Director, Center for Biologics Evaluation and Research (CBER) FDA
• Michael Lehmicke, Director, Science and Industry Affairs, Alliance for Regenerative Medicine (ARM) 
• Kelvin H. Lee, Institute Director, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
• Steven Goodman, Head of Drug Product Manufacturing, Bluebird Bio
• Vlad Hogenhuis, Chief Operating Officer (fmr.), Ultragenyx
  
  

Fill out the form to download the full event program to see what we have in store for you, and don't forget to secure your registration.

If you are interested in sponsoring or want additional information about the event, email enquiry@unitelifesciences.com.